Breaking News Instant updates and real-time market news.

MRK

Merck

$55.67

0.42 (0.76%)

16:52
03/16/18
03/16
16:52
03/16/18
16:52

Court rules Merck can be sued for generic drug injury, Reuters reports

The Massachusetts Supreme Judicial Court ruled that Merck and other brand name drug makers can be sued over injuries sustained on generic versions of its drugs if it failed to update warning labels, according to Reuters. Merck was originally sued because a 2011 Supreme Court decision prevents generic drug companies from being sued for inadequate warning labels.Reference Link

  • 25

    Mar

  • 03

    Apr

  • 04

    Apr

  • 23

    Apr

  • 24

    Apr

  • 23

    Oct

MRK Merck
$55.67

0.42 (0.76%)

03/02/18
LEER
03/02/18
NO CHANGE
Target $29
LEER
Outperform
Leerink ups Heron Therapeutics target to $29 after competitor setback
Leerink analyst Ami Fadia raised her price target for Heron Therapeutics (HRTX) to $29 from $27 after Tesaro (TSRO) announced earlier this week that it has withdrawn all promotional support for IV Varubi, based on numerous reports of anaphylaxis. Heron's Cinvanti, Tesaro's Varubi and Merck's (MRK) Emend are the only three branded NK-1 antagonists in the market today for chemo induced nausea and vomiting, Fadia tells investors in a research note. With Emend expected to go generic soon, Cinvanti will be the sole marketed branded agent, the analyst adds. She increased her 2023 estimate for Cinvanti from $150M to just under $200M and keeps an Outperform rating on Heron Therapeutics. The analyst continues to see upside for the stock ahead of the two Phase 3 trials for HTX-011 expected to read out in Q2.
03/12/18
LEER
03/12/18
UPGRADE
LEER
Outperform
Merck upgraded to Outperform from Market Perform at Leerink
03/12/18
LEER
03/12/18
UPGRADE
Target $66
LEER
Outperform
Leerink upgrades Merck to Outperform ahead of KN-189 presentation
Leerink analyst Seamus Fernandez upgraded Merck (MRK) to Outperform from Market Perform with an unchanged price target of $66. The shares closed Friday up 38c to $55.14. Keytruda will continue to dominate the first-line non-small cell lung cancer market, Fernandez tells investors in a research note. Following his firm's lung cancer survey, the analyst believes Merck will deliver upside to consensus Keytruda estimates along with positive earnings leverage in the second half of 2018 and 2019. He thinks KN-189 likely will show a clinically meaningful overall survival benefit for the Keytruda plus chemo combo in all patients, including a strong benefit in patients with moderate or low PD-L1 biomarker levels. Fernandez does not believe Bristol-Myers' (BMY) Opdivo and Yervoy combo will supplant Keytruda as the market leader. The analyst thinks now is the time to own shares of Merck.
03/12/18
03/12/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Time Warner (TWX) upgraded to Buy from Neutral at UBS with analyst John Hodulik saying while he expects the takeover by AT&T (T) to receive regulatory approval, he believes the current environment would make Time Warner's assets "highly attractive" to other media companies and Internet-based competitors were the deal to be blocked. 2. Carlyle Group (CG) and Apollo Global (APO) were upgraded to Buy from Neutral at Citi. 3. Merck (MRK) upgraded to Outperform from Market Perform at Leerink with analyst Seamus Fernandez saying Keytruda will continue to dominate the first-line non-small cell lung cancer market. 4. SAP (SAP) upgraded to Outperform from In Line at Evercore ISI with analyst Stewart Materne III saying that he believes the risk/reward is more attractive at current levels following the stock's 6% pullback. 5. Aratana Therapeutics (PETX) upgraded to Buy on valuation at CL King with the firm citing favorable risk/reward. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

CGC

Canopy Growth

$32.74

1.86 (6.02%)

11:25
08/17/18
08/17
11:25
08/17/18
11:25
Options
Canopy Growth call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$33.21

0.13 (0.39%)

, VIA

Viacom

$35.75

0.25 (0.70%)

11:19
08/17/18
08/17
11:19
08/17/18
11:19
Hot Stocks
Box Office Battle: 'Crazy Rich Asians' expected to edge out 'The Meg' »

The major release opening…

T

AT&T

$33.21

0.13 (0.39%)

VIA

Viacom

$35.75

0.25 (0.70%)

VIAB

Viacom

$30.60

0.5 (1.66%)

CMCSA

Comcast

$35.59

-0.07 (-0.20%)

CMCSK

Comcast

$0.00

(0.00%)

FOX

21st Century Fox

$44.86

-0.25 (-0.55%)

FOXA

21st Century Fox

$45.41

-0.3 (-0.66%)

LGF.A

Lionsgate

$22.90

-0.16 (-0.69%)

LGF.B

Lionsgate

$21.71

-0.24 (-1.09%)

SNE

Sony

$54.21

0.385 (0.72%)

DIS

Disney

$112.10

-0.39 (-0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

  • 11

    Sep

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
08/17/18
08/17
11:17
08/17/18
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
08/17/18
08/17
11:16
08/17/18
11:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:15
08/17/18
08/17
11:15
08/17/18
11:15
General news
Treasury Option Action: put butterfly positioning in the belly »

Treasury Option Action:…

BTC

Bitcoin

$0.00

(0.00%)

, BITCOIN

Bitcoin

$0.00

(0.00%)

11:13
08/17/18
08/17
11:13
08/17/18
11:13
Hot Stocks
The Intersection: Crypto and Wall Street This Week »

As bitcoin, ethereum and…

BTC

Bitcoin

$0.00

(0.00%)

BITCOIN

Bitcoin

$0.00

(0.00%)

TSM

TSMC

$39.87

-0.55 (-1.36%)

NVDA

Nvidia

$247.00

-10.57 (-4.10%)

AMD

AMD

$19.48

0.14 (0.72%)

OSTK

Overstock.com

$30.75

0.55 (1.82%)

DPW

DPW Holdings

$0.42

0.019 (4.76%)

KODK

Kodak

$2.90

-0.1 (-3.33%)

SSC

Seven Stars Cloud Group

$1.99

0.01 (0.51%)

RIOT

Riot Blockchain

$5.35

-0.055 (-1.02%)

TEUM

Pareteum

$2.52

-0.01 (-0.40%)

SRAX

Social Reality

$4.18

-0.16 (-3.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 28

    Aug

  • 12

    Sep

11:05
08/17/18
08/17
11:05
08/17/18
11:05
General news
The U.S. QSS figures »

The U.S. QSS figures that…

NVDA

Nvidia

$247.12

-10.45 (-4.06%)

, ESPR

Esperion

$48.10

1.41 (3.02%)

11:04
08/17/18
08/17
11:04
08/17/18
11:04
Recommendations
Fly Intel: Today's top analyst calls on Wall Street »

Check out today's…

NVDA

Nvidia

$247.12

-10.45 (-4.06%)

ESPR

Esperion

$48.10

1.41 (3.02%)

DSW

DSW

$25.85

-1.97 (-7.08%)

MTCH

Match Group

$46.87

0.49 (1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 12

    Sep

  • 12

    Sep

FIBK

First Interstate

$45.20

(0.00%)

11:02
08/17/18
08/17
11:02
08/17/18
11:02
Hot Stocks
First Interstate completes acquisition of Northwest Bancorporation »

Effective August 16,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

LB

L Brands

$32.34

0.24 (0.75%)

11:00
08/17/18
08/17
11:00
08/17/18
11:00
Options
Defensive one-week option play in L Brands ahead of earnings »

Defensive one-week option…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

SYMC

Symantec

$19.44

0.115 (0.60%)

10:40
08/17/18
08/17
10:40
08/17/18
10:40
Options
Symantec sees in the money put buying »

Symantec sees in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

DE

Deere

$136.75

-0.63 (-0.46%)

10:39
08/17/18
08/17
10:39
08/17/18
10:39
Hot Stocks
Breaking Hot Stocks news story on Deere »

Deere says cash use…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

TSLA

Tesla

$313.73

-21.73 (-6.48%)

10:37
08/17/18
08/17
10:37
08/17/18
10:37
Technical Analysis
Technical Take: Tesla nearing bearish head and shoulders target »

In a note published here…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

PK

Park Hotels & Resorts

$32.15

-0.19 (-0.59%)

10:36
08/17/18
08/17
10:36
08/17/18
10:36
Hot Stocks
Park Hotels & Resorts mentioned positively by Hedgeye »

Hedgeye made positive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:35
08/17/18
08/17
10:35
08/17/18
10:35
General news
FX Action: Cable is set to rack up a sixth consecutive week of declines »

FX Action: Cable is set…

WBK

Westpac Banking

$21.99

0.09 (0.41%)

10:33
08/17/18
08/17
10:33
08/17/18
10:33
Downgrade
Westpac Banking rating change  »

Westpac Banking…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

DE

Deere

$137.29

-0.09 (-0.07%)

10:31
08/17/18
08/17
10:31
08/17/18
10:31
Hot Stocks
Deere expects FY18 net operating cash flows from equipment operations $3.5B »

Says had another…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

SPY

SPDR S&P 500 ETF Trust

$283.54

-0.55 (-0.19%)

10:30
08/17/18
08/17
10:30
08/17/18
10:30
Options
Bullish end of year play in SPYders »

Bullish end of year play…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:25
08/17/18
08/17
10:25
08/17/18
10:25
General news
The Michigan sentiment drop to an 11-month low »

The Michigan sentiment…

GERN

Geron

$3.99

0.04 (1.01%)

10:20
08/17/18
08/17
10:20
08/17/18
10:20
Options
Geron draws far upside call buyers »

Geron draws far upside…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

10:20
08/17/18
08/17
10:20
08/17/18
10:20
General news
U.S. leading indicator rose 0.6% to 110.7 in July »

U.S. leading indicator…

DARE

Dare Bioscience

$1.01

0.01 (1.00%)

, WSC

WillScot

$16.10

0.2 (1.26%)

10:18
08/17/18
08/17
10:18
08/17/18
10:18
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…click here.

DARE

Dare Bioscience

$1.01

0.01 (1.00%)

WSC

WillScot

$16.10

0.2 (1.26%)

LGND

Ligand

$237.18

-2.66 (-1.11%)

COT

Cott Corp.

$15.98

0.34 (2.17%)

AZRE

Azure Power

$15.95

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

DF

Dean Foods

$8.01

-0.62 (-7.18%)

, WAB

Wabtec

$108.87

-1.73 (-1.56%)

10:17
08/17/18
08/17
10:17
08/17/18
10:17
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…click here.

DF

Dean Foods

$8.01

-0.62 (-7.18%)

WAB

Wabtec

$108.87

-1.73 (-1.56%)

YUMC

Yum China

$34.48

-0.85 (-2.41%)

DSW

DSW

$25.77

-2.05 (-7.37%)

SUI

Sun Communities

$101.22

-0.895 (-0.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 10

    Sep

  • 12

    Sep

  • 06

    Nov

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
08/17/18
08/17
10:17
08/17/18
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
08/17/18
08/17
10:16
08/17/18
10:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.